{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:33:22Z","timestamp":1781253202766,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Incontentia pigmenti (IP) is a rare multisystem disorder of ectodermal origin comprising skin, dental, ocular and central nervous system features. Symptomatic treatments are adapted to each family according to the patient\u2019s disability. Due to its rarity, the family IP burden in its broadest sense (psychological, social, economic and physical) has not yet been evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To design a questionnaire allowing assessing the family burden of IP (F\u2019BoIP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A questionnaire was developed using a standardized methodology for designing quality of life questionnaires according to the following steps: conception, development, and validation. A multidisciplinary working group was designed, including experts in questionnaire development, dermatologists specialised in IP patient care and representatives of the French IP association. A cultural and linguistic validation into US English was conducted, based on the original French version.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A 20-item conceptual questionnaire was generated. Subsequent confirmatory analyses produced a 20-item questionnaire grouped into four domains, demonstrating internal consistency (Cronbach\u2019s alpha: 0.93), reproducibility and high reliability. The F\u2019BoIP questionnaire significantly correlated with other validated questionnaires: Family Dermatology Life Quality Index (F-DLQI), Perceived Stress Scale (PSS) and SF-12 mental and SF12 physical scores, indicating good external validity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The F\u2019BoIP questionnaire is the first specific tool to assess the family burden of IP and can be used by both family members of IP patients and by health care professionals. It is a valuable tool which evaluates medical and nonmedical strategies to improve the daily life of families affected by this orphan disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-019-1234-y","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T15:03:14Z","timestamp":1574780594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incontinentia pigmenti burden scale: designing a family burden questionnaire"],"prefix":"10.1186","volume":"14","author":[{"name":"the Fili\u00e8re Maladies Rares en Dermatologie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-2479","authenticated-orcid":false,"given":"Charles","family":"Taieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smail","family":"Hadj-Rabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"1234_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/35013114","volume":"405","author":"A Smahi","year":"2000","unstructured":"Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The international Incontinentia Pigmenti (IP) consortium. Nature. 2000;405:466\u201372.","journal-title":"Nature"},{"key":"1234_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2147\/TCRM.S134705","volume":"13","author":"A Alshenqiti","year":"2017","unstructured":"Alshenqiti A, Nashabat M, AlGhoraibi H, et al. Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report. Ther Clin Risk Manag. 2017;13:629\u201334.","journal-title":"Ther Clin Risk Manag"},{"key":"1234_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/jmg.30.1.53","volume":"30","author":"SJ Landy","year":"1993","unstructured":"Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993;30:53\u20139.","journal-title":"J Med Genet"},{"key":"1234_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/cge.12223","volume":"85","author":"S Minic","year":"2014","unstructured":"Minic S, Trpinac D, Obradovic M. Incontinentia pigmenti diagnostic criteria update. Clin Genet. 2014;85:536\u201342.","journal-title":"Clin Genet"},{"key":"1234_CR5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1468-3083.2010.03600.x","volume":"24","author":"N Meyer","year":"2010","unstructured":"Meyer N, Paul C, Feneron D, et al. Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol. 2010;24:1075\u201382.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1234_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2340\/00015555-1847","volume":"95","author":"O Boccara","year":"2015","unstructured":"Boccara O, Meni C, Leaute-Labreze C, et al. Haemangioma family burden: creation of a specific questionnaire. Acta Derm Venereol. 2015;95:78\u201382.","journal-title":"Acta Derm Venereol"},{"key":"1234_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1172-8-28","volume":"8","author":"H Dufresne","year":"2013","unstructured":"Dufresne H, Hadj-Rabia S, M\u00e9ni C, et al. Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis. 2013;8:28.","journal-title":"Orphanet J Rare Dis"},{"key":"1234_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2340\/00015555-1945","volume":"95","author":"A Taieb","year":"2015","unstructured":"Taieb A, Boralevi F, Seneschal J, et al. Atopic dermatitis burden scale for adults: development and validation of a new assessment tool. Acta Derm Venereol. 2015;95:700\u20135.","journal-title":"Acta Derm Venereol"},{"key":"1234_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/JID.2015.398","volume":"136","author":"C Salzes","year":"2016","unstructured":"Salzes C, Abadie S, Seneschal J, et al. The Vitiligo impact patient scale (VIPs): development and validation of a Vitiligo burden assessment tool. J Invest Dermatol. 2016;136:52\u20138.","journal-title":"J Invest Dermatol"},{"key":"1234_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-018-0894-3","volume":"13","author":"F Morice-Picard","year":"2018","unstructured":"Morice-Picard F, Taieb C, Marti A, et al. Burden of albinism: development and validation of a burden assessment tool. Orphanet J Rare Dis. 2018;13:162.","journal-title":"Orphanet J Rare Dis"},{"key":"1234_CR11","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1111\/jdv.15563","volume":"33","author":"G Hickman","year":"2019","unstructured":"Hickman G, Bodemer C, Bourrat E, et al. Palmoplantar keratoderma: creating a disease burden questionnaire. J Eur Acad Dermatol Venereol. 2019;33:e291\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1234_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2133.2006.07617.x","volume":"156","author":"MK Basra","year":"2007","unstructured":"Basra MK, Sue-Ho R, Finlay AY. The family dermatology life quality index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528\u201338.","journal-title":"Br J Dermatol"},{"key":"1234_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/014107680109401103","volume":"94","author":"J Rees","year":"2001","unstructured":"Rees J, O'Boyle C, MacDonagh R. Quality of life: impact of chronic illness on the partner. J R Soc Med. 2001;94:563\u20136.","journal-title":"J R Soc Med"},{"key":"1234_CR14","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/jdv.14288","volume":"31","author":"F Sampogna","year":"2017","unstructured":"Sampogna F, Finlay AY, Salek SS, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2017;31:1429\u201339.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1234_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/01688639408402620","volume":"16","author":"M Seidenberg","year":"1994","unstructured":"Seidenberg M, Haltiner A, Taylor MA, et al. Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol. 1994;16:93\u2013104.","journal-title":"J Clin Exp Neuropsychol"},{"key":"1234_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02289233","volume":"23","author":"HF Kaiser","year":"1958","unstructured":"Kaiser HF. The varimax criterion for analytic rotation in factor analysis. Pyschometrika. 1958;23:187\u2013200.","journal-title":"Pyschometrika"},{"key":"1234_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","volume":"107","author":"PM Bentler","year":"1990","unstructured":"Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107:238\u201346.","journal-title":"Psychol Bull"},{"key":"1234_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026409226544","volume":"8","author":"LL Lim","year":"1999","unstructured":"Lim LL, Fisher JD. Use of the 12-item short-form (SF-12) health survey in an Australian heart and stroke population. Qual Life Res. 1999;8:1\u20138.","journal-title":"Qual Life Res"},{"key":"1234_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385\u201396.","journal-title":"J Health Soc Behav"},{"key":"1234_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94\u2013104.","journal-title":"Value Health"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1234-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T19:16:56Z","timestamp":1722107816000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1234-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1234"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1234-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The questionnaire construction was carried out as part of the RADICO-FARD project, which obtained a favorable opinion from the Committee for the Protection of Individuals (CPP Ouest V, Rennes) on July 31, 2017.The questionnaire was proposed by the patient association, and at no time did the authors of the project or the persons in charge of the analgesia statistics know the identity of the responders.There was no way to make a connection between the answers obtained and the person who answered the questionnaire.The respondents were provided with an information sheet before giving their consent. This information sheet as well as the consent form clearly explained the purpose of the project and guaranteed the anonymity of the responses.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}